Results 161 to 170 of about 27,986 (275)
Cellular Senescence, Inflammaging and Cardiovascular Disease
Immunological Reviews, Volume 337, Issue 1, January 2026.ABSTRACT Aging is the most important yet unmodifiable risk factor for cardiovascular disease (CVD). As a result, targeting cardiovascular aging has emerged as a promising strategy to promote long‐term cardiovascular health. This review summarizes current knowledge on the effects of aging within the cardiovascular system as well as systemic processes ...
Lukas Zanders +3 more
wiley +1 more source
بی حسی اپيدورال برای سزارين درخانم مبتلا به بيماری کارديوميوپاتی هيپرتروفيک-معرفی بيمار [PDF]
, 2015 بی حسی اپيدورال برای سزارين درخانم مبتلا به بيماری کارديوميوپاتی هيپرتروفيک –معرفی بيمار مقدمه : تغييرات پاتوفيزيولوژی کارديو ميو پاتی هيپر تروفيک پيچيده است و تغييرات فيزيولوژی حاملگی و اثرات بيهوشی برای جراحی سزارين باعث تغييرات بارزی روی هموديناميک می
اسماعیلی, وحید +2 more
core
Effect of Beta-Blocker Therapy on the Response to Mavacamten in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy [PDF]
, 2022 Matthew T. Wheeler +10 more
openalex +1 more source
Cardiovascular Therapeutics, Volume 2026, Issue 1, 2026.Aims To evaluate the real‐world efficacy and safety of low‐dose (2.5 mg) mavacamten initiation in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Methods and Results This single‐center observational study (Zhongshan Hospital, China; Oct 2024–Apr 2025) enrolled 72 symptomatic oHCM patients (NYHA II/III, LVEF ≥ 55 ...
Wenlong Yang +9 more
wiley +1 more source
Case Reports in Critical Care, Volume 2026, Issue 1, 2026.Background Primary cardiac sarcomas are rare and aggressive tumors that often present with nonspecific symptoms, typically diagnosed at advanced stages. Obstruction of the left ventricular outflow tract (LVOT) due to these tumors is an exceptionally rare and life‐threatening complication.
Tomás de la Barra +8 more
wiley +1 more source
Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy [PDF]
, 2017 Aims Cardiovascular magnetic resonance (CMR) has improved diagnostic and management strategies in hypertrophic cardiomyopathy (HCM) by expanding our appreciation for the diverse phenotypic expression. We sought to characterize the prevalence and clinical
Appelbaum, Evan +18 more
core
Mavacamten for hypertrophic obstructive cardiomyopathy [PDF]
The Lancet, 2021 Eduard, Quintana +2 more
openaire +2 more sources
Journal of Interventional Cardiology, Volume 2026, Issue 1, 2026.Background Percutaneous intramyocardial (PIM) septal pulsed field ablation (SPFA) represents an innovative technique for the management of hypertrophic obstructive cardiomyopathy. However, the paucity of pertinent animal models has impeded comprehensive investigation. This study aimed to assess the safety, efficacy, and feasibility of PIM‐SPFA, as well
Xing-an Zhao +10 more
wiley +1 more source
The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients [PDF]
, 2023 J. Hans DeVries +2 more
openalex +1 more source